IP Library › Granted Patent US 9,913,681
Granted Patent B2
US 9,913,681 · App. 14/428,448 · Granted Mar 13, 2018

Ablation device using bipolar steam generation

Inventor: Daniel A. Beaudet (Lexington, MA)
Assignee: HOLOGIC, INC.
A61B18/1485A61B18/1233A61B2018/00065A61B2018/00154A61B2018/00559A61B2018/00577A61B2018/00702A61B2018/00875A61B2018/1405A61B2018/1472A61B2018/1497A61B2217/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,913,681
App. No.
14/428,448
Filed
Mar 16, 2015
Granted
Mar 13, 2018
Kind
B2
Art Unit
3739
USPC
606/41
Abstract

An ablation device includes first and second electrodes and an absorbent medium. The ablation device may include a permeable spacer or other mechanisms to position the ablation device in the uterus. The absorbent medium configured to absorb a conductive fluid and optionally to distend. A current can be applied to the first and second electrodes to convert the conductive fluid to a vapor or steam for ablation of the uterus.

Claims (18)

1. An intrauterine ablation device, comprising:

a working end configured for transcervical insertion into, and to thereafter be expanded within, a patient's uterus, the working end comprising a permeable spacer, the permeable spacer having an outward-facing surface and an inward-facing surface, wherein when the working end is inserted into and expanded within the patient's uterus, the inward-facing surface of the permeable spacer defines an interior region; and

an electrode assembly disposed within the interior region defined by the inward-facing surface of the permeable spacer, the electrode assembly including

a first electrode comprising a generally planar permeable body having an inward-facing surface,

a second electrode comprising a generally planar permeable body having an inward-facing surface facing the inward-facing surface of the first electrode, and

a layer of absorbent material disposed between the inward-facing surfaces of the first and second electrodes, the absorbent material being configured to absorb a conductive fluid so as to electrically couple the first electrode to the second electrode when a current is provided to one of the first or second electrodes.

2. The intrauterine ablation device of claim 1 , further comprising a fluid conduit configured to provide the conductive fluid to the absorbent medium.

3. The intrauterine ablation device of claim 1 , further comprising at least one suction tube configured to channel any of fluid, steam, and vapor away from the electrode assembly.

4. The intrauterine ablation device of claim 3 , wherein the at least one suction tube is positioned and arranged to be near a fallopian tube opening when the working end is inserted into, and expanded within, the patient's uterus.

5. The intrauterine ablation device of claim 3 , wherein the at least one suction tube comprises two suction tubes, each positioned and arranged to be near a fallopian tube opening when the working end is inserted into, and expanded within, the patient's uterus.

6. The intrauterine ablation device of claim 1 , wherein the layer of absorbent material comprises an osmotic dilator.

7. The intrauterine ablation device of claim 1 , further comprising an eluting component configured to administer an anesthetic to a patient.

8. The intrauterine ablation device of claim 1 , further comprising an elongate support member defining an elongate axis, wherein the working end is coupled to a distal portion of the elongate support member, and wherein the respective inward-facing surfaces of the first and second electrodes are disposed generally parallel to each other and to the elongate axis.

9. The intrauterine ablation device of claim 1 ,

the first electrode further comprising an outward-facing surface underlying and facing opposite the inward-facing surface of the first electrode, and

the second first electrode further comprising an outward-facing surface underlying and facing opposite the inward-facing surface of the second electrode,

wherein the respective outward-facing surfaces of the first and second electrodes face in opposite directions and are each apposing the inward-facing surface of the permeable spacer.

10. The intrauterine ablation device of claim 1 , wherein the inward-facing surface of the first electrode overlays a first surface of the layer of absorbent material, and the inward-facing surface of the second electrode overlays a second surface of the layer of absorbent material underlying and facing opposite the first surface of the layer of absorbent material.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 075926/0339 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL FRAME 035593 0560 Recorded Jul 17, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 036128/0282 →
SECURITY INTEREST Recorded May 8, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNESHIP; DIRECT RADIOGRAPHY CORP.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 035593/0560 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2015
From: BEAUDET, DANIEL A.
To: HOLOGIC, INC.
Reel/Frame 035171/0396 →
Continuity (2)
Provisional Application 61702926 · Sep 19, 2012
Related Publication 20150223876A1 · Aug 13, 2015